ARCHIVES

Phase III Avastin Trial Fails Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

CDC To Award $23 Mil. To States for Screening

April 26, 1991

NCI Sets Rules For Omics Studies

October 18, 2013

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001